Cargando…

Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA

Synthetic cannabinoid receptor agonists (SCRAs) remain popular drugs of abuse. As many SCRAs are known to be mostly metabolized, in vitro phase I metabolic profiling was conducted of the two indazole-3-carboxamide SCRAs: CUMYL-THPINACA and ADAMANTYL-THPINACA. Both compounds were incubated using pool...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monti, Manuela Carla, Scheurer, Eva, Mercer-Chalmers-Bender, Katja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398790/ https://www.ncbi.nlm.nih.gov/pubmed/34436411 http://dx.doi.org/10.3390/metabo11080470

Ejemplares similares

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA
por: Kevin, Richard C., et al.
Publicado: (2017)

Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE
por: Mogler, Lukas, et al.
Publicado: (2018)

Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services
por: Monti, Manuela Carla, et al.
Publicado: (2022)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
por: Kevin, Richard C., et al.
Publicado: (2019)

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
por: Angerer, Verena, et al.
Publicado: (2018)

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
por: Kevin, Richard C., et al.
Publicado: (2022)

Quantitative determination of five cannabinoids in blood and urine by gas chromatography tandem mass spectrometry applying automated on‐line solid phase extraction
por: Frei, Priska, et al.
Publicado: (2022)

Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models
por: Dahm, Patrick, et al.
Publicado: (2021)

Beyond Δ9-tetrahydrocannabinol and cannabidiol: chemical differentiation of cannabis varieties applying targeted and untargeted analysis
por: Monti, Manuela Carla, et al.
Publicado: (2022)

Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability – a randomized clinical trial
por: Egloff, Laura, et al.
Publicado: (2023)

Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report
por: McIlroy, Graham, et al.
Publicado: (2016)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting
por: May, Benedict, et al.
Publicado: (2019)

Influence of the Synthetic Cannabinoid Agonist on Normal and Inflamed Cartilage: An In Vitro Study
por: Shang, Jiangyinzi, et al.
Publicado: (2023)

Enantioseparation of P-Stereogenic 1-Adamantyl Arylthiophosphonates and Their Stereospecific Transformation to 1-Adamantyl Aryl-H-phosphinates
por: Varga, Bence, et al.
Publicado: (2023)

In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist
por: Burstein, Sumner H, et al.
Publicado: (2013)

Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists
por: Sachdev, Shivani, et al.
Publicado: (2020)

Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights
por: Malaca, Sara, et al.
Publicado: (2021)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Zagzoog, Ayat, et al.
Publicado: (2021)

(1-Adamantyl)(2-methylphenyl)methanone
por: Babjaková, Eva, et al.
Publicado: (2010)

Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity
por: Worob, Adam, et al.
Publicado: (2022)

(1-Adamantyl)diphenylmethanol
por: Vícha, Robert, et al.
Publicado: (2010)

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
por: Brents, Lisa K., et al.
Publicado: (2011)

Assessment of the Abuse Liability of Synthetic Cannabinoid Agonists JWH-030, JWH-175, and JWH-176
por: Tampus, Reinholdgher, et al.
Publicado: (2015)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
por: Jackson, Melissa A., et al.
Publicado: (2021)

Might synthetic cannabinoids influence neural differentiation?
por: Bekman, Evguenia, et al.
Publicado: (2021)

Effects of Adamantyl Derivatives on Pharmacokinetic Behavior of Paclitaxel in Rats
por: Kim, Kyung Mi, et al.
Publicado: (2017)

Adamantyl and homoadamantyl derivatives from Garcinia multiflora fruits
por: Chen, Yu, et al.
Publicado: (2019)

2-(1-Adamantyl)-1,3-diphenylpropan-2-ol
por: Babjaková, Eva, et al.
Publicado: (2010)

Effectiveness of the synthetic cannabinoids seminar
por: Seyit, Murat, et al.
Publicado: (2016)

Synthetic cannabinoids and renal injury
por: Alp, Alper
Publicado: (2015)

Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
por: Giorgetti, Arianna, et al.
Publicado: (2020)

Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
por: Craft, Sam, et al.
Publicado: (2021)

(1-Adamantyl)(3-aminophenyl)methanone
por: Rouchal, Michal, et al.
Publicado: (2011)

(1-Adamantyl)(4-aminophenyl)methanol
por: Rouchal, Michal, et al.
Publicado: (2009)

4-[(1-Adamantyl)carbamoyl]pyridinium chloride
por: Wang, Yingchun
Publicado: (2010)

Synthesis and Bioactivity of Hydrazide-Hydrazones with the 1-Adamantyl-Carbonyl Moiety
por: Pham, Van Hien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b9vp281pphve419mel4t0lhnlb